Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer

INTRODUCTION: Recently, contrast-enhanced mammography (CEM) has emerged as a reliable alternative to breast magnetic resonance imaging (MRI) for the assessment of pathological response in breast cancer patients. Our study sought to determine the diagnostic accuracy of CEM to predict pathological com...

Descripción completa

Detalles Bibliográficos
Autores principales: Canteros, Daniel, Walbaum, Benjamin, Córdova-Delgado, Miguel, Torrealba, Andrés, Reyes, Constanza, Navarro, María Elena, Razmilic, Dravna, Camus, Mauricio, Dominguez, Francisco, Navarrete, Orieta, Pinto, Mauricio P, Pizarro, Gonzalo, Acevedo, Francisco, Sánchez, César
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300406/
https://www.ncbi.nlm.nih.gov/pubmed/35919242
http://dx.doi.org/10.3332/ecancer.2022.1396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300406/
https://www.ncbi.nlm.nih.gov/pubmed/35919242
http://dx.doi.org/10.3332/ecancer.2022.1396

Ejemplares similares